Sartar Therapeutics
Sartar Therapeutics is a preclinical stage company developing treatments for soft tissue sarcomas. Soft tissue sarcomas are a heterogenous group of rare tumours with only limited treatment options currently available. for advanced disease. Sartar is dedicated to deliver innovative therapeutic options and hope for sarcoma patients.
| Location | Finland |
| Website | sartartherapeutics.com |
| Founded | 2016 |
| Employees | 1-10 |
| Industries | Healthcare & Life Science |
| Business model | B2B |
| Funding state | Seed |
Working at
Sartar Therapeutics
This job comes with several perks and benefits
Flexible working hours
Near public transit
Remote work allowed
“We give new life and purpose to an older drug, anagrelide, with targeted sarcoma therapy.”
Harri Sihto,
Founder, Chairman of the Board